DGNS schedules rights issue to acquire Asa Ren
18 Apr 2024 10:42
PT Diagnos Laboratorium Utama Tbk (DGNS) will conduct rights issue of a maximum of 921 billion new shares worth IDR 25 per share.
18 Apr 2024 10:42
PT Diagnos Laboratorium Utama Tbk (DGNS) will conduct rights issue of a maximum of 921 billion new shares worth IDR 25 per share.
01 Apr 2024 07:58
PT Bundamedik Tbk (BMHS), the managing company of a network of hospitals and other healthcare service providers, only scored net profit of IDR 7.46 billion in 2023.
05 Mar 2024 11:35
PT Diagnos Laboratorium Utama Tbk (DGNS), a medical laboratory service provider under PT Bundamedik Tbk (BMHS), booked a loss of IDR 13.65 billion in 2023.